抗戊型肝炎病毒免疫球蛋白 G 携带患者丙型肝炎病毒治疗成功后戊型肝炎病毒感染：再激活还是再感染？
Hepatitis E Virus (HEV) Infection in Anti-HEV Immunoglobulin G-Carrying Patients After Successful Hepatitis C Virus Treatment: Reactivation or Reinfection?
机构信息
Unidad de Enfermedades Infecciosas and.
Servicio de Análisis Clínico, Hospital Universitario Reina Sofía de Córdoba, Instituto Maimonides de Investigación Biomédica de Córdoba, Universidad de Córdoba; and.
出版信息
Clin Infect Dis. 2017 Apr 1;64(7):964-966. doi: 10.1093/cid/cix004.
Although hepatitis E virus (HEV) is regarded as a self-limiting infection and anti-HEV antibodies seem to protect against reinfection, its pathogenesis is not well established. We describe 2 cases of acute symptomatic HEV infection after hepatitis C therapy in patients carrying anti-HEV immunoglobulin G antibodies, raising 2 major questions: reactivation or reinfection?
虽然戊型肝炎病毒（HEV）被认为是一种自限性感染，抗-HEV 抗体似乎可以防止再次感染，但它的发病机制尚未完全确定。我们描述了 2 例在携带抗-HEV 免疫球蛋白 G 抗体的患者中，丙型肝炎治疗后出现急性有症状的 HEV 感染的病例，提出了 2 个主要问题：再激活还是再感染？
Zotero 插件